Idexx Laboratories (IDXX)

Nasdaq Health Care Health Care Equipment S&P 500Nasdaq-100

$676.04

+5.33 (+0.79%)

Close of Nov 06, 2026 · end-of-day data

Source: Idexx Laboratories's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.78B	$1.97B	$2.21B	$2.41B	$2.71B	$3.22B	$3.37B	$3.66B	$3.90B	$4.30B
Cost of revenue	$799.99M	$871.68M	$971.70M	$1.04B	$1.14B	$1.33B	$1.36B	$1.47B	$1.52B	$1.64B
Gross profit	$975.44M	$1.10B	$1.24B	$1.37B	$1.57B	$1.89B	$2.00B	$2.19B	$2.38B	$2.66B
Research & development	$101.12M	$109.18M	$117.86M	$133.19M	$141.25M	$161.01M	$254.82M	$190.95M	$219.79M	$251.21M
Operating income	$350.24M	$413.03M	$491.33M	$552.85M	$694.52M	$932.03M	$898.76M	$1.10B	$1.13B	$1.36B
Interest expense	$32.05M	$37.23M	$34.74M	$31.05M	$33.12M	$29.81M	$39.86M	$41.58M	$31.20M	$38.85M
Pre-tax income	$321.85M	$381.06M	$457.74M	$522.22M	$661.99M	$902.65M	$859.97M	$1.06B	$1.11B	$1.32B
Income tax	$99.79M	$117.79M	$80.69M	$94.43M	$79.85M	$157.81M	$180.88M	$216.13M	$221.96M	$264.73M
Net income	$222.04M	$263.14M	$377.03M	$427.72M	$581.78M	$744.85M	$679.09M	$845.04M	$887.87M	$1.06B
EBITDA	$428.46M	$496.17M	$574.51M	$640.86M	$790.52M	$1.04B	$1.01B	$1.21B	$1.26B	$1.51B
EPS (basic)	$2.47	$3.00	$4.34	$4.97	$6.82	$8.74	$8.12	$10.17	$10.77	$13.17
EPS (diluted)	$2.44	$2.94	$4.26	$4.89	$6.71	$8.60	$8.03	$10.06	$10.67	$13.08
Diluted shares	90.88M	89.57M	88.47M	87.54M	86.72M	86.57M	84.60M	83.98M	83.25M	81.03M
Gross margin	54.9%	55.7%	56.1%	56.7%	58.0%	58.8%	59.5%	59.8%	61.0%	61.8%
Operating margin	19.7%	21.0%	22.2%	23.0%	25.7%	29.0%	26.7%	30.0%	29.0%	31.6%
Net margin	12.5%	13.4%	17.0%	17.8%	21.5%	23.2%	20.2%	23.1%	22.8%	24.6%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$154.90M	$187.68M	$123.79M	$90.33M	$383.93M	$144.45M	$112.55M	$453.93M	$288.27M	$180.07M
Short-term investments	$236.95M	$284.25M	$0	—	—	—	—	—	—	—
Receivables	$204.49M	$234.60M	$248.85M	$269.31M	$331.43M	$368.35M	$400.62M	$457.44M	$473.57M	$552.38M
Inventory	$158.03M	$164.32M	$173.30M	$195.02M	$209.87M	$269.03M	$367.82M	$380.28M	$381.88M	$377.76M
Total current assets	$845.58M	$971.99M	$654.17M	$679.64M	$1.06B	$955.65M	$1.10B	$1.50B	$1.40B	$1.41B
Goodwill	$178.23M	$199.87M	$214.49M	$239.72M	$243.35M	$359.35M	$361.80M	$366.00M	$405.10M	$414.00M
Total assets	$1.53B	$1.71B	$1.54B	$1.83B	$2.29B	$2.44B	$2.75B	$3.26B	$3.29B	$3.35B
Total current liabilities	$934.57M	$1.00B	$770.44M	$725.34M	$582.76M	$763.58M	$1.24B	$951.55M	$1.07B	$1.15B
Short-term debt	—	—	—	$0	$49.99M	$75.00M	$74.98M	$75.00M	$167.79M	$75.00M
Long-term debt	$593.70M	$606.60M	$601.80M	$698.91M	$858.49M	$775.21M	$694.39M	$622.88M	$449.79M	$374.84M
Total debt	$593.70M	$606.60M	$601.80M	$698.91M	$908.48M	$850.20M	$769.37M	$697.88M	$617.57M	$449.84M
Total liabilities	$1.64B	$1.77B	$1.55B	$1.65B	$1.66B	$1.75B	$2.14B	$1.78B	$1.70B	$1.75B
Shareholders' equity	-$108.35M	-$54.11M	-$9.51M	$177.47M	$632.09M	$689.99M	$608.74M	$1.48B	$1.60B	$1.61B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$338.94M	$373.28M	$400.08M	$459.16M	$648.06M	$755.55M	$542.98M	$906.51M	$929.00M	$1.18B
Capital expenditures	$64.79M	$74.38M	$115.75M	$154.97M	$106.96M	$119.55M	$148.84M	$133.63M	$120.92M	$124.68M
Free cash flow	$274.16M	$298.89M	$284.33M	$304.19M	$541.11M	$636.00M	$394.15M	$772.88M	$808.08M	$1.06B
Investing cash flow	-$90.79M	-$138.69M	$138.60M	-$205.53M	-$109.38M	-$292.97M	-$195.35M	-$125.25M	-$207.06M	-$136.24M
Financing cash flow	-$222.20M	-$208.02M	-$597.80M	-$286.41M	-$248.42M	-$697.41M	-$370.94M	-$442.00M	-$878.07M	-$1.16B
Share buybacks	$304.09M	$282.56M	$369.32M	$301.66M	$182.81M	$746.78M	$819.71M	$71.92M	$837.03M	$1.22B
Stock-based compensation	$19.89M	$23.52M	$25.16M	$39.28M	$30.95M	$37.76M	$49.77M	$59.74M	$60.30M	$60.01M
Depreciation & amortization	$78.22M	$83.14M	$83.18M	$88.01M	$96.00M	$104.60M	$111.90M	$114.91M	$129.94M	$145.18M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$901.60M	$964.10M	$1.00B	$975.54M	$954.29M	$998.43M	$1.11B	$1.11B	$1.09B	$1.14B	$1.22B	$1.21B
Cost of revenue	$375.43M	$371.02M	$384.42M	$379.50M	$383.63M	$375.05M	$414.73M	$421.88M	$432.46M	$418.08M	$437.50M	$449.94M
Gross profit	$526.17M	$593.07M	$619.16M	$596.04M	$570.66M	$623.38M	$694.73M	$683.35M	$658.11M	$722.74M	$779.09M	$764.30M
Research & development	$51.81M	$52.63M	$55.45M	$53.98M	$57.73M	$59.06M	$61.90M	$63.41M	$66.83M	$65.79M	$65.43M	$68.82M
Operating income	$245.30M	$298.96M	$263.80M	$303.89M	$261.69M	$316.53M	$373.05M	$354.85M	$315.61M	$362.59M	$425.57M	$402.35M
Interest expense	$9.27M	$7.91M	$8.10M	$7.70M	$7.50M	$7.67M	$11.32M	$10.65M	$9.21M	$7.74M	$10.18M	$7.46M
Pre-tax income	$239.67M	$295.48M	$259.06M	$298.91M	$256.39M	$310.08M	$362.35M	$344.77M	$306.98M	$355.44M	$417.22M	$399.32M
Income tax	$45.15M	$59.90M	$55.76M	$66.07M	$40.24M	$67.41M	$68.36M	$70.16M	$58.79M	$77.00M	$78.81M	$82.18M
Net income	$194.52M	$235.58M	$203.30M	$232.84M	$216.15M	$242.68M	$293.99M	$274.61M	$248.19M	$278.45M	$338.41M	$317.14M
EBITDA	$275.04M	$328.86M	$295.99M	$338.02M	$295.39M	$350.60M	$408.82M	$391.47M	$354.33M	$400.27M	$466.62M	$442.91M
EPS (basic)	$2.34	$2.84	$2.46	$2.83	$2.65	$2.98	$3.66	$3.43	$3.11	$3.50	$4.29	$4.02
EPS (diluted)	$2.31	$2.81	$2.44	$2.80	$2.62	$2.96	$3.63	$3.40	$3.09	$3.47	$4.27	$4.01
Diluted shares	-12.00K	83.96M	83.39M	83.06M	-232.00K	81.92M	80.99M	80.67M	-182.00K	80.16M	79.31M	79.05M
Gross margin	58.4%	61.5%	61.7%	61.1%	59.8%	62.4%	62.6%	61.8%	60.3%	63.4%	64.0%	62.9%
Operating margin	27.2%	31.0%	26.3%	31.2%	27.4%	31.7%	33.6%	32.1%	28.9%	31.8%	35.0%	33.1%
Net margin	21.6%	24.4%	20.3%	23.9%	22.7%	24.3%	26.5%	24.8%	22.8%	24.4%	27.8%	26.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$453.93M	$397.43M	$401.59M	$308.64M	$288.27M	$163.97M	$164.59M	$208.17M	$180.07M	$200.53M	$196.93M	$197.54M
Receivables	$457.44M	$507.21M	$533.61M	$511.25M	$473.57M	$527.46M	$560.56M	$566.88M	$552.38M	$603.54M	$627.08M	$615.80M
Inventory	$380.28M	$390.60M	$379.96M	$389.80M	$381.88M	$395.99M	$392.58M	$391.56M	$377.76M	$382.40M	$391.58M	$390.87M
Total current assets	$1.50B	$1.50B	$1.53B	$1.43B	$1.40B	$1.32B	$1.36B	$1.48B	$1.41B	$1.45B	$1.51B	$1.50B
Goodwill	$366.00M	$408.67M	$408.02M	$412.07M	$405.10M	$407.49M	$414.49M	$413.65M	$414.00M	$412.10M	$410.95M	$640.51M
Total assets	$3.26B	$3.35B	$3.41B	$3.35B	$3.29B	$3.21B	$3.33B	$3.39B	$3.35B	$3.39B	$3.44B	$3.71B
Total current liabilities	$951.55M	$956.90M	$1.12B	$1.01B	$1.07B	$1.14B	$1.22B	$1.25B	$1.15B	$1.30B	$1.29B	$1.26B
Short-term debt	$75.00M	$75.00M	$170.11M	$99.14M	$167.79M	$170.93M	$74.99M	$150.00M	$75.00M	$150.00M	$150.00M	$75.00M
Long-term debt	$622.88M	$620.78M	$524.74M	$524.76M	$449.79M	$449.80M	$449.81M	$374.82M	$374.84M	$299.85M	$299.87M	$299.88M
Total debt	$697.88M	$695.78M	$694.86M	$623.90M	$617.57M	$620.73M	$524.81M	$524.82M	$449.84M	$449.85M	$449.86M	$374.88M
Total liabilities	$1.78B	$1.78B	$1.83B	$1.73B	$1.70B	$1.77B	$1.87B	$1.83B	$1.75B	$1.83B	$1.83B	$1.84B
Shareholders' equity	$1.48B	$1.57B	$1.58B	$1.62B	$1.60B	$1.45B	$1.46B	$1.56B	$1.61B	$1.56B	$1.61B	$1.87B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$249.85M	$198.59M	$248.31M	$220.08M	$262.02M	$237.96M	$185.74M	$402.34M	$355.76M	$266.25M	$347.16M	$449.72M
Capital expenditures	$32.56M	$30.27M	$33.30M	$28.09M	$29.25M	$30.03M	$34.10M	$31.11M	$29.43M	$31.98M	$24.65M	$28.93M
Free cash flow	$217.29M	$168.31M	$215.01M	$191.99M	$232.77M	$207.94M	$151.64M	$371.23M	$326.33M	$234.26M	$322.52M	$420.79M
Investing cash flow	-$30.43M	-$106.94M	-$32.91M	-$27.37M	-$39.84M	-$29.61M	-$33.63M	-$44.87M	-$28.13M	-$33.54M	-$25.50M	-$248.10M
Financing cash flow	-$101.84M	-$144.07M	-$210.24M	-$290.98M	-$232.78M	-$330.32M	-$165.63M	-$313.31M	-$355.70M	-$211.43M	-$325.19M	-$200.85M
Share buybacks	$36.85M	$154.76M	$215.52M	$220.76M	$245.99M	$400.89M	$338.11M	$240.19M	$237.77M	$351.04M	$346.80M	$112.17M
Stock-based compensation	$15.22M	$14.40M	$15.72M	$15.92M	$14.26M	$14.62M	$14.85M	$14.43M	$16.11M	$16.34M	$16.09M	$16.22M
Depreciation & amortization	$29.74M	$29.90M	$32.19M	$34.13M	$33.71M	$34.06M	$35.77M	$36.63M	$38.72M	$37.68M	$41.05M	$40.56M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.